Biotech
ViroPharma is buying Lev for $442M
Lev Pharma, that focuses on inflammatory diseases is being acquired by ViroPharma for $442 Million. ViroPharma is paying $2.25 per share in cash and 50 cents per share in stock. more... Discuss | | by Jitendra 89 days ago (fiercebiotech.com)Omeros Corporation Files for $115 Million IPO
Biotech startup Omeros Corporation filed for a $115 Million IPO. Deutsche Bank Securities Inc. will be acting as the sole book-running manager. Pacific Growth Equities, LLC will be acting as the co- lead more... Discuss | | by Jitendra 261 days ago (biospace.com)Alder Biopharmaceuticals Gets $40M Series C Financing
Alder Biopharmaceuticals, Inc., an antibody therapeutics startup, today announced the its Series C financing. Delphi Ventures and TPG Biotech led the $40 million round. Also participating in the round more... Discuss | | by Jitendra 275 days ago (biospace.com)UK tech start-ups
Some of the hottest emerging companies - Inscentinel, Imense, Monitise, Ionscope more... 3 Comments | | by G2g 390 days ago (news.bbc.co.uk)Amyris Biotechnologies gets $70M
Amyris Biotech got Series B funding from DAG Ventures. more... Discuss | | by Jitendra 388 days ago (topix.net)The busy life of a Biotech startup founder
Jim Hardy of Gahaha BioSciences shares his detailed insights on the life of Biotech startup founder in this blogterview with Attila Chordash, who edits the blog. Some interesting tidbits emerge as the more... Discuss | | by Jitendra 362 days ago (pimm.wordpress.com)Biotech pesticide maker AgraQuest raises $20M
In its 10th round of funding, Davis based BioTech major AgraQuest has raised $20M from U.K.’s Loudwater Trust and existing investors, including TPG Ventures. AgraQuest derives novel, organic pesticides more... Discuss | | by Jitendra 312 days ago (venturebeat.com)« previous1 next »
| © 2007 StartupNewz.com | Login | Join | Top Users | Tag Cloud | FAQ | Contact us | Silicon Valley Blog | Podcasts | Photo Album | XHTML CSS |
